Please login to the form below

Not currently logged in
Email:
Password:

Stada

This page shows the latest Stada news and features for those working in and with pharma, biotech and healthcare.

Stada's €4.1bn takeover goes through

Stada's €4.1bn takeover goes through

Stada's 4.1bn takeover goes through. German pharma company finally comes under new ownership. ... After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain and Cinven

Latest news

More from news
Approximately 9 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    The 2008 financial crash is a salutary reminder. Given this background what do we make of the deal where two private equity companies, Bain and Cinven, joined forces to acquire Stada ... So why did Bain/Cinven acquire Stada at a high price? Almost

  • Deal Watch February 2017 Deal Watch February 2017

    What is more than rumour, is the interest from several parties in acquiring the German generic company, Stada, which has pan-European capabilities and a foothold in Russia. ... Whatever happens to Stada this represents another chapter in the evolution of

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    485. OptiMedica  /. Abbott. Acquisition. Ophthalmic device company. 400. Thornton &Ross /. Stada Arzneimittel. Acquisition. OTC manufacturer. 345. Endosense  /. St Jude Medical.

  • Pharma deals during August 2013 Pharma deals during August 2013

    In a defensive move the German drugmaker Stada Arzneimittel announced the $345m take-over of the UK OTC company, Thornton &Ross.Thornton &Ross is one of the fastest growing companies in ... the UK pharmaceutical market (11 per cent sales growth over the

  • Pharma deals during November 2012 Pharma deals during November 2012

    Veropharm, one of the largest generics companies in the fast-growing Russian market has, not surprisingly, been the subject of interest from companies such as GSK and Stada for some time.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Britannia promotes Robert Wood Britannia promotes Robert Wood

    Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics